New proprietary computational methods will be applied to assign biological functions to novel proteins in the genome of Mycobacterium tuberculosis, the causative agent of tuberculosis. Traditional computational methods can only assign functions to genome sequences that are homologs of other previously characterized proteins. The new algorithms developed by Protein Pathways, Inc. use other types of information derived from transgenomic analysis to assign functions to proteins that cannot be characterized by traditional computational methods. The methods will assign probable functions to as many as 1,000 uncharacterized TB protein sequences. Many of the proteins will be identified as having roles in virulence and will therefore be attractive targets for future drug development efforts.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI047533-01
Application #
6140960
Study Section
Special Emphasis Panel (ZRG1-SSS-K (01))
Program Officer
Sizemore, Christine F
Project Start
2000-04-01
Project End
2000-09-30
Budget Start
2000-04-01
Budget End
2000-09-30
Support Year
1
Fiscal Year
2000
Total Cost
$98,306
Indirect Cost
Name
Protein Pathways, Inc.
Department
Type
DUNS #
City
Los Angeles
State
CA
Country
United States
Zip Code
90024